LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

DSM - top 3 food global ingredients supplier and food tech development. holds 28%.

aspirin from foxglove? .... i thought it was digitalis for lactating mothers!

De Ja Vue the graph indicates a similar run to yesterday. Traget raised to 12p

found something re market and licenses for anti-thrombotic and platelet aggregation inhibitors; selected paragraphs here, link below. I'm not a pharmasist/expert - so this may be parallel - but still gives sense of license deals/market size. there is a hint of decling market but this is still huge.

February 27, 2009
decision by Novartis to license phase II anti-clotting agent elinogrel from private US biotech Portola Pharmaceuticals for USD 75 million upfront.
Although the full terms of the deal were not disclosed, the upfront fee suggests this is the biggest product deal in this field since Pfizer licensed apixaban, whilst in phase III trials, from Bristol-Myers Squibb for USD 250 million upfront in April 2007.

However, the patent expiry for Plavix, the industrys second biggest product in 2008 with sales of USD 9.43 billion behind Lipitor at USD 12.4 billion, means that revenues for this class of drug are forecast to decline seven percent annually to USD 8.1 billion by 2014.

full article here;
http://www.ebdgroup.com/partneringnews/?q=node/153

oops you're right cynic--digitalis from foxgloves for heart disease I think. Aspirin comes from some plant I think but just can't remember!

m
aspirin comes from the bark of a tree,cant remember which one. however this may ,or may not, explain the old witches brew which contained the bark of a tree plus "other" ingrediants,maybe those other ingredients might also be proven in time. i think one of those "brews" included frogs.
no doubt someone might enlighten us.
regards
jkd

http://www.moneyam.com/InvestorsRoom/posts.php?tid=14368#lastread

dd
if you are going to spam at least make it easy for me. Lol
regards
jkd
edit thanks ian and team

25% up today! Iam happy with that. Got to be some rns tmrw. imho

I bought my orange/pomegranate sirco today in H&B sales are going very well and the assistant was very interested to know what effect the drink had on consumers and why it's selling well. very pleased with the rise today so took out my original stake and will let the rest run long term. Hoodless is utter rubbish couldn't sell even 25k online with them!

as a long term holder..(from 3.65p a few yrs ago but also topped up at 1p recently) .....I'm continuing to hold.... I sold a few the other day at6p as I needed some cash...

Will stay in whatever the outcome (long term should be fantastic).....

the past week has been fun and would rather be in than out !

Been in from about 18 months ago at about 2p, sold yesterday at 6p as I couldn't see the rise continuing, will get back in at some point as I think the potential is huge.

sp falling rapidly is this yet another over ramped share?

greedy tossers like me have been deservedly nibbled!
fortunately not a huge amount at stake even if sp goes to zero, but isn't there a post somewhee mentioning an AGM or similar in the near future.

cynic will it bottom at 3p?

Agm 10th September.

halifax asking the arch tosser's opinion - whatever next??!!
i see the hoped-for support at 3p, but whether or not it holds remains to be seen

bouncing now shorters covering?

that was my thought .... closed at 4.75/4.8 after a low of 4.0

Great Thanks to spiritfinder for calling and asking very intelligent questions. This should put peoples minds at rest re the forward momentum of the company if not the very short term share price swings which are out of their hands. We are still a big jump up from where this has languished over the past year.


I've just spoken to Mr. Steve Morrison, the Chief operating Officer at Provexis;

Q.How quickly would we expect the EU wording approval?

A. That could be days or a few weeks

Q. Could it be months

A. Have to appreciate that the timing is out of our hands. However, bearing in mind that the 60day period has elapsed and looking at the minutes of the last meeting, we can assume a positive outcome in a matter of days or perhaps afew weeks. We don't see any major problems with the EU wording approval!

Q. Can we assume that the Licensing deals will be signes dependent on the EU wording approval

A. It's safe to assume that our partners are looking very closely at the final approval but bear in mind that we are the only company in our field to have obtained the EFSA approval

Q. Lot's of speculation regarding a Takeover and Mr. moon promising shareholders maximum advantage in the medium to Long term

A. You need to refer to that statement and bear in mind that we've just started Phase11 trials which our recent RNS states. That's the actions of a company with a comitted and long term approach!

Q. How would you value the company

A. Not sure what you mean by that but bear in mind that we are the only company with EFSA approval and have a tremendous amount of interest in our product.

Q. What are your thoughts on the edison Analyst's opinion that "nothing has changed since last year...."


Q. What are your thoughts on the edison Analyst's opinion that "nothing has changed since last year...."

A. He laughed first....things have fundamentally changed with the EFSA approval. I haven't seen the analyst's comments but we don't have anytghing to do with Edison!

mr. morrison was very positive on the phone and kept refering to "could be days", only mentioning posiibly afew weeks when pushed!

Again, reinforces my belief that this company and its share price are set to soar. Please feel fre to validate any of the information by contacting the company yourselves!